At Ipca Laboratories Ltd., our commitment to ensuring safety of drugs goes beyond mere compliance. We understand the need and importance of monitoring drug safety - right from the discovery of the medicine throughout the life of the drug.

Drug safety is an important consideration for all stakeholders involved with drugs, right from the health care professionals, who are medically qualified persons, such as physicians, dentists, pharmacists, nurses and coroners to patients who consume the drug, to drug regulatory authorities and pharmaceutical companies who are involved in manufacturing and marketing of the drugs.

Though drugs come to clinical practice only after they are proven safe in clinical trials, rare adverse events can surface anytime during their life cycle. All drugs are normally associated with the possibility of adverse events and are prescribed only when the beneficial effects override consideration of any adverse events, which may result from its use.

Pharmacovigilance activity has hence been initiated by Ipca as a dedicated function to ensure consistent drug safety.

Pharmacovigilance function comprises of the following:

• Detection
• Assessment & evaluation
• Understanding and
• Prevention

We have comprehensive systems in place for detecting and rapidly evaluating potential risk due to adverse report of medicines.

We assess the adverse event reports received from health care professionals and consumers from countries, where Ipca's products are marketed. We review the adverse event reports published in medical journals and scientific literature. We also evaluate safety of our products through clinical trials and post marketing surveillance studies. We train our sales representatives, both in domestic and international market on various aspects of pharmacovigilance and how to do adverse event reporting. Necessary actions are taken based on the assessment of the adverse event reports.

With above activities, we try to ensure safe and rational use of medicines.

If you wish to report a suspected adverse reaction occurred with our drug, please download the Adverse Event Reporting Form, complete it, and send it to us in any one of the following ways:

(Click to download Adverse Event Reporting Form)

*In case, you are not able to download the Adverse Event Reporting Form, you can even obtain it by choosing any mode (Representative, Phone, Fax, Email) as mentioned below.

• Call: +91 22 6647 4630
• Fax the form on Fax No. +91 22 2868 6954 / 2868 2875
• Scan the form and email at pharmacovigilance.mumbai@ipca.com
• Courier the form at:
  Corporate Pharmacovigilance Cell
  Ipca Laboratories Limited
  142-AB, Kandivli Industrial Estate
  Kandivli (West)
  Mumbai 400 067
  India

or Fill it here

Note: Fields marked by * are compulsory